(Q54331823)

27 May 2018

title

Chimeric flagellin as the self-adjuvanting antigen for the activation of immune response against Helicobacter pylori. (English)

1 reference

27 May 2018

0 references

9

1 reference

27 May 2018

Mojca Benčina

8

object named as

Mojca Benčina

1 reference

27 May 2018

Jerneja Mori

1

1 reference

27 May 2018

Tanja Vranac

2

1 reference

27 May 2018

Boštjan Smrekar

3

1 reference

27 May 2018

Maja Cernilec

4

1 reference

27 May 2018

Vladka Čurin Serbec

5

1 reference

27 May 2018

Simon Horvat

6

1 reference

27 May 2018

Alojz Ihan

7

1 reference

27 May 2018

language of work or name

English

0 references

publication date

20 July 2012

1 reference

27 May 2018

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

27 May 2018

volume

30

1 reference

27 May 2018

issue

40

1 reference

27 May 2018

page(s)

5856-5863

1 reference

27 May 2018

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

1 reference

Helicobacter pylori infection induces gastric cancer in mongolian gerbils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Helicobacter pylori flagellins have very low intrinsic activity to stimulate human gastric epithelial cells via TLR5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Evasion of Toll-like receptor 5 by flagellated bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Variation in bacterial flagellins: from sequence to structure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Complete atomic model of the bacterial flagellar filament by electron cryomicroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Divergence of quaternary structures among bacterial flagellar filaments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Structure of the bacterial flagellar protofilament and implications for a switch for supercoiling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Enteroaggregative Escherichia coli expresses a novel flagellin that causes IL-8 release from intestinal epithelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Deletion of flagellin's hypervariable region abrogates antibody-mediated neutralization and systemic activation of TLR5-dependent immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Humoral immune response to flagellin requires T cells and activation of innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Reconstitution of a functional Toll-like receptor 5 binding site in Campylobacter jejuni flagellin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

A recombinant flagellin-poxvirus fusion protein vaccine elicits complement-dependent protection against respiratory challenge with vaccinia virus in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Flagellin as an adjuvant: cellular mechanisms and potential.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

DNA released from dying host cells mediates aluminum adjuvant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Immunologic adjuvants for modern vaccine formulations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Vaccine strategies: targeting helper T cell responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Cellular mechanisms of the adjuvant activity of the flagellin component FljB of Salmonella enterica Serovar Typhimurium to potentiate mucosal and systemic responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Responses to the soluble flagellar protein FliC are Th2, while those to FliC on Salmonella are Th1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Toll-like receptors control activation of adaptive immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Silica Crystals and Aluminum Salts Regulate the Production of Prostaglandin in Macrophages via NALP3 Inflammasome-Independent Mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

Dynamics of acute and memory mucosal and systemic immune responses against HIV-1 envelope following immunizations through single or combinations of mucosal and systemic routes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.07.011

10.1016/J.VACCINE.2012.07.011

7 January 2021

Identifiers

DOI

1 reference

27 May 2018

1 reference

27 May 2018